Imperva (IMPV) Tops Q4 EPS by 5c, Q1 & FY16 Guidance Falls Short

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Imperva (IMPV) Tops Q4 EPS by 5c, Q1 & FY16 Guidance Falls Short

Needham & Company Reiterates Buy Following Imperva's (IMPV) 4Q Beat and Raise

February 4, 2016 6:45 AM EST

Needham & Company maintained a Buy rating on Imperva (NYSE: IMPV), and cut the price target to $56.00 (from $88.00), following the company's 4Q earnings report. IMPVs $72.7m and $0.20 was comfortably above $68.1m and $0.15 EPS consensus, yet investor expectations were high going into earnings. CY16 old guidance was for $285m, and last night IMPV revised... More